abstract |
The invention relates to peptides for combating the autoantibodies that have a causal pathological relationship with dilatative cardiomyopathy (DCM). Said peptides can be e.g. bonded to a solid phase. Said autoantibodies can be eliminated by treating the blood of patients with DCM with the inventive peptides. |